In a neurology update for investors, Roche touted data from a small Ib/IIa trial for trontinemab, an investigational therapy for Alzheimer’s disease which demonstrated “rapid and robust” amyloid plaque reduction.
Tag Archive for: study data
After treatment with a CD19 CAR-T therapy, patients with systemic lupus erythematosus, idiopathic inflammatory myositis or systemic sclerosis achieved long-lasting remission, according to results published in the NEJM.
Can decentralized and agile approaches also be applied to LTFUs and the collection of real-world evidence (RWE)? What does that look like, who’s interested in pursuing it, and what are the perceived benefits and pitfalls?